Amphotericin B Injectable, Liposomal
Product Images NDC 62756-233
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amphotericin B (NDC 62756-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Spl-amphotercin-structure (Spl Amphotercin Structure)
Spl-carton-1s (Spl Carton 1s)
Amphotericin B Liposome for Injection is a prescription drug that contains 50mg of the active ingredient, amphotericin B, in a liposomal membrane consisting of alpha-tocopherol, cholesterol, distearoyiphosphatcyighcerol, sodium saf, and hydrogenated soy phosphatcylcholine. The drug is distributed by Sun Pharmaceatical Industries and manufactured by Sun Pharmaceatical Medicare Limited. It is meant for intravenous infusion only and must be reconstituted and diluted before use. The drug is stored at temperatures between 20°C and 25°C and is not interchangeable or substitutable with other amphotericin B products on a milligram-per-milligram basis.*
Spl-figure1 (Spl Figure1)
Spl-figure2 (Spl Figure2)
This appears to be a chart or graph showing mean creatinine concentration (in mg/dL) for patients who had a pretreatment value greater than 1.7 mg/dL, specifically related to "Al episodes." The x-axis appears to show the day of the test, with measurements taken on days 10, 20, 30, 40, and 50. Without more context, it's difficult to determine what the data represents or what it may be used for.*
Spl-label (Spl Label)
Amphotericin B Liposome for Injection is a sterile, non-pyrogenic solution used for intravenous infusion only. It is a liposomal formulation containing 50 mg of Amphotericin B, alpha-tocopherol, cholesterol, distearoylphosphatidyigycerol, sodium saccharide, and hydroxylated soy phosphatidyicholine. The buffer used is disodium succinate hexahydrate and sucrose. The product must be reconstituted and further diluted before use. It may contain hydrochloric acid and/or sodium hydroxide as pH adjusters. It is not interchangeable or substitutable on a mg per mg basis with other Amphotericin B products. The product should be stored between 20°C to 25°C. The usual dosage and route of administration should be based on the prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.